Large‐Scale, Prospective Observational Study of Regorafenib in Japanese Patients with Metastatic Colorectal Cancer in a Real‐World Clinical Setting

BACKGROUND. Regorafenib improved the overall survival (OS) of patients with metastatic colorectal cancer (mCRC) who progress after standard therapies in two phase III trials. The present large‐scale prospective observational study evaluated the safety and effectiveness of regorafenib administered to...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncologist
Autors principals: Yamaguchi, Kensei, Komatsu, Yoshito, Satoh, Taroh, Uetake, Hiroyuki, Yoshino, Takayuki, Nishida, Toshirou, Yamazaki, Naoya, Takikawa, Hajime, Morimoto, Takashi, Chosa, Masayuki, Sunaya, Toshiyuki, Hamada, Yoko, Muro, Kei, Sugihara, Kenichi
Format: Artigo
Idioma:Inglês
Publicat: John Wiley & Sons, Inc. 2019
Matèries:
Gastrointestinal Cancer
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6656456/
https://ncbi.nlm.nih.gov/pubmed/30606885
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2018-0377
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars